Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025The Open Public Health JournalOpen Access

Liraglutide in Obesity Management: Evidence of Weight and Lipid Improvements in a UAE Cohort

View Full Paper
Ask AI
Bookmark
Share

Authors

FAFathelrahman AhmedRashid HospitalTMTarig MerghaniRas al-Khaimah Medical and Health Sciences UniversityMAMaryam AlkhatryKing Hamad University Hospital

Discussion

Loading...

Member takes

Implication

Retrospective analysis shows liraglutide improves weight and LDL-C in non-diabetic obesity, indicating its role in treatment.

Key Points

  • Mean weight decreased by 6.8%, achieving significant reductions in both weight and LDL-C over 12 months.
  • Glycosylated hemoglobin (HbA1c) showed a modest decline, from 6.33% to 6.11%, indicating improvements in glycaemic control.
  • The study included 209 patients with obesity, primarily UAE nationals and females, offering insights into this demographic's response to treatment.
  • Liraglutide demonstrated effective weight loss and lipid improvements, supporting its use alongside lifestyle changes in similar populations.

Cite This Study

Ahmed et al. (2025) studied this question.

synapsesocial.com/papers/68c1b1a154b1d3bfb60e9228https://doi.org/10.2174/0118749445420434250723055026
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity2024 · 6 citations
  2. 2Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus2024 · 7 citations
  3. 3Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial2024 · 77 citations
  4. 4Evaluation of the efficacy of low‐dose liraglutide in weight control among Taiwanese non‐diabetes patients2020 · 25 citations
  5. 5Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events2016 · 875 citations